RVL Pharmaceuticals plc Revenue
RVL Pharmaceuticals plc reported Revenue of $8.26 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2023-08-14
- RVL Pharmaceuticals plc revenue from contract with customer, excluding assessed tax for the quarter ending 2023-06-30 was $8.26M, a 2.25% decline year-over-year.
- RVL Pharmaceuticals plc revenue from contract with customer, excluding assessed tax for the quarter ending 2023-03-31 was $8.83M, a 58.81% decline year-over-year.
- RVL Pharmaceuticals plc revenue from contract with customer, excluding assessed tax for the quarter ending 2022-12-31 was $9.81M, a 242.90% increase year-over-year.
- RVL Pharmaceuticals plc revenue from contract with customer, excluding assessed tax for the quarter ending 2022-09-30 was $10.02M, a 356.38% increase year-over-year.
- RVL Pharmaceuticals plc revenue from contract with customer, excluding assessed tax for fiscal 2022 was $49.72M, a 184.10% increase from fiscal 2021.
- RVL Pharmaceuticals plc revenue from contract with customer, excluding assessed tax for fiscal 2021 was $17.50M, a 36.96% decline from fiscal 2020.
- RVL Pharmaceuticals plc revenue from contract with customer, excluding assessed tax for fiscal 2020 was $27.76M.
- RVL Pharmaceuticals plc revenue from contract with customer, excluding assessed tax for fiscal 2018 was $263.70M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 12 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | $8.26M 10-Q · filed 2023-08-14 | $17.09M 10-Q · filed 2023-08-14 | $26.90M derived: sum of 3 quarters · filed 2023-08-14 | $36.92M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2023-03-31 | $8.83M 10-Q · filed 2023-05-11 | $18.64M derived: sum of 2 quarters · filed 2023-05-11 | $28.66M derived: sum of 3 quarters · filed 2023-05-11 | $37.11M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-12-31 | $9.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $19.83M derived: sum of 2 quarters · filed 2023-03-20 | $28.28M derived: sum of 3 quarters · filed 2023-08-14 | $49.72M 10-K · filed 2023-03-20 | ||||
| 2022-09-30 | $10.02M 10-Q · filed 2022-11-10 | $18.47M derived: sum of 2 quarters · filed 2023-08-14 | $39.91M 10-Q · filed 2022-11-10 | $42.77M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-06-30 | $8.45M 10-Q · filed 2023-08-14 | $29.89M 10-Q · filed 2023-08-14 | $32.75M derived: sum of 3 quarters · filed 2023-08-14 | $34.95M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $21.44M 10-Q · filed 2023-05-11 | $24.30M derived: sum of 2 quarters · filed 2023-05-11 | $26.50M derived: sum of 3 quarters · filed 2023-05-11 | $38.01M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $5.06M derived: sum of 2 quarters · filed 2023-03-20 | $16.57M derived: sum of 3 quarters · filed 2023-03-20 | $17.50M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | $2.20M 10-Q · filed 2022-11-10 | $13.71M derived: sum of 2 quarters · filed 2022-11-10 | $14.64M 10-Q · filed 2022-11-10 | $15.78M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $11.51M 10-Q · filed 2022-08-11 | $12.45M 10-Q · filed 2022-08-11 | $13.58M derived: sum of 3 quarters · filed 2022-08-11 | $39.33M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $935.00K 10-Q · filed 2022-05-12 | $23.88M 10-Q · filed 2021-05-13 | $2.07M derived: sum of 2 quarters · filed 2022-05-12 | $27.82M derived: sum of 3 quarters · filed 2022-05-12 | $28.05M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $26.89M derived: sum of 2 quarters · filed 2022-03-30 | $27.12M derived: sum of 3 quarters · filed 2022-03-30 | $27.76M 10-K · filed 2022-03-30 | $177.88M 10-K · filed 2021-03-30 | |||
| 2020-09-30 | $25.75M 10-Q · filed 2021-11-15 | $57.17M 10-Q · filed 2020-11-10 | $25.98M derived: sum of 2 quarters · filed 2021-11-15 | $26.63M 10-Q · filed 2021-11-15 | $143.35M 10-Q · filed 2020-11-10 | -$104.28M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $234.00K 10-Q · filed 2021-08-16 | $37.53M 10-Q · filed 2020-08-11 | $464.00K 10-Q · filed 2021-08-16 | $86.18M 10-Q · filed 2020-08-11 | -$130.03M derived: sum of 3 quarters · filed 2021-09-08 | -$64.57M derived: sum of 4 quarters · filed 2021-09-08 | ||
| 2020-03-31 | $48.65M 10-Q · filed 2021-05-13 | -$130.27M derived: sum of 2 quarters · filed 2021-09-08 | -$64.81M derived: sum of 3 quarters · filed 2021-09-08 | -$7.28M derived: sum of 4 quarters · filed 2021-09-08 | ||||
| 2019-12-31 | -$178.92M derived: 8-K 12 month − 10-Q 9 month · filed 2021-09-08 | -$113.46M derived: sum of 2 quarters · filed 2021-09-08 | -$55.92M derived: sum of 3 quarters · filed 2021-09-08 | $1.20M 8-K · filed 2021-09-08 | $240.03M 10-K · filed 2020-03-19 | |||
| 2019-09-30 | $65.46M 10-Q · filed 2020-11-10 | $65.46M 10-Q · filed 2019-11-14 | $122.99M derived: sum of 2 quarters · filed 2020-11-10 | $180.12M 10-Q · filed 2020-11-10 | $180.12M 10-Q · filed 2019-11-14 | $245.82M derived: sum of 4 quarters · filed 2020-11-10 | ||
| 2019-06-30 | $57.53M 10-Q · filed 2020-08-11 | $57.53M 10-Q · filed 2019-08-08 | $114.66M 10-Q · filed 2020-08-11 | $114.66M 10-Q · filed 2019-08-08 | $180.35M derived: sum of 3 quarters · filed 2020-08-11 | $246.70M derived: sum of 4 quarters · filed 2020-08-11 | ||
| 2019-03-31 | $57.13M 10-Q · filed 2020-05-12 | $57.13M 10-Q · filed 2019-05-09 | $122.82M derived: sum of 2 quarters · filed 2020-05-12 | $189.17M derived: sum of 3 quarters · filed 2020-05-12 | $261.03M derived: sum of 4 quarters · filed 2020-05-12 | |||
| 2018-12-31 | $65.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $132.04M derived: sum of 2 quarters · filed 2020-03-19 | $203.90M derived: sum of 3 quarters · filed 2020-03-19 | $263.70M 10-K · filed 2020-03-19 | $263.70M 10-K · filed 2019-03-28 | |||
| 2018-09-30 | $66.34M 10-Q · filed 2019-11-14 | $138.20M derived: sum of 2 quarters · filed 2019-11-14 | $198.00M 10-Q · filed 2019-11-14 | $274.34M derived: sum of 4 quarters · filed 2019-12-20 | ||||
| 2018-06-30 | $71.86M 10-Q · filed 2019-08-08 | $131.66M 10-Q · filed 2019-08-08 | $207.99M derived: sum of 3 quarters · filed 2019-12-20 | $261.73M derived: sum of 4 quarters · filed 2019-12-20 | ||||
| 2018-03-31 | $59.80M 10-Q · filed 2019-05-09 | $136.13M derived: sum of 2 quarters · filed 2019-12-20 | $189.87M derived: sum of 3 quarters · filed 2019-12-20 | |||||
| 2017-12-31 | $76.33M derived: 8-K 12 month − 10-Q 9 month · filed 2019-12-20 | $130.07M derived: sum of 2 quarters · filed 2019-12-20 | $245.75M 8-K · filed 2019-12-20 | |||||
| 2017-09-30 | $53.74M 10-Q · filed 2018-11-08 | $169.42M 10-Q · filed 2018-11-08 |